Octreotide (Octreoscan) / Somatostatin Scintigraphy

Octreotide (Octreoscan) / Somatostatin Scintigraphy in Marrakech

Nuclear Medicine Physician

It concerns the management of neuroendocrine tumors (Neuroendocrine tumors (NETs) start in cells of the neuroendocrine system.) With the following objectives:
- detection and localization of the primary tumor.
- assessment of the extent of metastases and pre-treatment classification.
- detection of recurrence and tumor progression as part of monitoring.
- monitoring and evaluation of the therapeutic effect of surgery, chemotherapy and radiotherapy.
-patient selection for therapeutic octreotide